Bank of Nova Scotia
TSX:BNS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bank of Nova Scotia
TSX:BNS
|
CA |
|
P
|
Phibro Animal Health Corp
F:PB8
|
US |
|
C
|
Constellation Software Inc
DUS:W9C
|
CA |
|
Athens Medical Center SA
F:ACS
|
GR |
|
Ecolab Inc
NYSE:ECL
|
US |
|
B
|
Brown & Brown Inc
DUS:BTW
|
US |
|
C
|
Carnegie Clean Energy Ltd
F:CNM1
|
AU |
Intrinsic Value
Is BNS undervalued or overvalued?
See the intrinsic value estimate for Bank of Nova Scotia and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
BNS looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with BNS’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Bank of Nova Scotia Does
Bank of Nova Scotia, better known as Scotiabank, is a large Canadian bank that takes deposits, makes loans, issues credit cards, and helps customers with everyday banking. It serves individuals, small businesses, and larger companies through branches, online banking, and commercial banking teams. It also offers wealth management, insurance, and investment banking services for customers who need more specialized financial help.
- Headquarters
- Canada CA
- Employees
- 80 415
- IPO date
- Mar 17, 1980
Bank of Nova Scotia has a narrow economic moat
Moving linked accounts, payments and loans takes time and can bring fees or payment disruptions, giving Scotiabank a lasting reason for customers to stay. Its Canadian banking bundles deepen these ties by connecting mortgage pricing with everyday banking and other products.
Read the full moat analysis
The intrinsic value for Bank of Nova Scotia (BNS) under the Base Case is hidden CAD.
Compared with the current market price of 130 CAD, the stock appears hidden.